Advertisement

Protein oxidation markers in women with and without gestational diabetes mellitus: A possible relation with paraoxonase activity

Published:September 01, 2011DOI:https://doi.org/10.1016/j.diabres.2011.08.001

      Abstract

      Aims

      To clarify the levels of protein oxidation markers such as protein carbonyl (PCO), protein hydroperoxides (P-OOH), advanced oxidation protein products (AOPP) and nitrotyrosine (NT), as well as antioxidative enzymes such as paraoxonase (PON-1) in women with and without gestational diabetes mellitus (GDM).

      Methods

      The study was conducted on 23 women with GDM and 22 women without GDM. The levels of the P-OOH, AOPP, and PON-1 were determined by colorimetric methods; whereas NT and PCO levels were measured by ELISA.

      Results

      The concentrations of protein oxidation markers were significantly increased and PON1 activity was significantly decreased in GDM group compared to those of normal pregnant women. The control group showed a significant negative correlation between PON-1 and PCO (r = −0.451, p = 0.027); whereas in GDM group, there was a significant positive correlation between P-OOH and HbA1c (r = 0.89, p = 0.001). There was no significant correlation between AOPP, PON-1, P-OOH, PCO, and HbA1c in either group.

      Conclusions

      There is evidence of a possible association between protein oxidation and decreased PON1 activity in GDM. The increase in protein oxidation parameters in the GDM group leading to decreased PON1 activity might, we think, create a predisposition for clinical complications in GDM group.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Agarwal A.
        • Gupta S.
        • Sharma R.K.
        Role of oxidative stress in female reproduction.
        Reprod Biol Endocrinol. 2005; 3: 28
        • Mackness M.I.
        • Mackness B.
        • Durrington P.N.
        • Connelly P.W.
        • Hegele R.A.
        Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.
        Curr Opin Lipidol. 1996; 7: 69-76
        • Jaouad L.
        • Guise C.
        • Berrougui H.
        • Cloutier M.
        • Isabelle M.
        • Fulop T.
        • et al.
        Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups.
        Atherosclerosis. 2006; 185: 191-200
        • Gugliucci A.
        • Lunceford N.
        • Kinugasa E.
        • Ogata H.
        • Schulze J.
        • Kimura S.
        Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
        Clin Chim Acta. 2007; 384: 105-112
        • Woods A.A.
        • Linton S.M.
        • Davies M.J.
        Detection of HOCl mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.
        Biochem J. 2003; 370: 729-735
        • Kaneda H.
        • Taguchi J.
        • Ogasawara K.
        • Aizawa T.
        • Ohno M.
        Increased level of advanced oxidation protein products in patients with coronary artery disease.
        Atherosclerosis. 2002; 162: 221-225
        • Skvarilová M.
        • Bulava A.
        • Stejskal D.
        • Adamovská S.
        • Bartek J.
        Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.
        Biomed Pap. 2005; 149: 83-87
        • Stadtman E.R.
        • Levine R.L.
        Protein oxidation.
        Ann N Y Acad Sci. 2000; 899: 191-208
        • Dean R.T.
        • Fu S.
        • Stocker R.
        • Davies M.J.
        Biochemistry and pathology of radical-mediated protein oxidation.
        Biochem J. 1997; 324: 1-18
        • Shacter E.
        Protein oxidative damage.
        Methods Enzymol. 2000; 319: 428-436
        • Bindoli A.
        • Rigobello M.P.
        Mitochondrial thioredoxin reductase and thiol status.
        Methods Enzymol. 2002; 347: 307-316
        • Netto L.E.
        • Kowaltowski A.J.
        • Castilho R.F.
        • Vercesi A.E.
        Thiol enzymes protecting mitochondria against oxidative damage.
        Methods Enzymol. 2002; 348: 260-270
        • Ischiropoulos H.
        • Al-Mehdi A.B.
        Peroxynitrite-mediated oxidative protein modification.
        FEBS Lett. 1995; 364: 279-282
        • Gow A.J.
        • Duran D.
        • Malcolm S.
        • Ischiropoulos H.
        Effect of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation.
        FEBS Lett. 1996; 385: 63-66
        • Halliwell B.
        What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo.
        FEBS Lett. 1997; 411: 157-160
        • Ter steege J.C.A.
        • Koster-Kamphuis L.
        • Van Straaten E.A.
        • Forget P.P.
        • Buurman W.A.
        Nitrotyrosine in plasma of coeliac disease patients as detected by a new sandwich ELISA.
        Free Radic Biol Med. 1998; 25: 953-963
        • Witko V.
        • Nguyen A.T.
        • Descamps-Latscha B.
        Microtiter plate assay for phagocyte derivered taurine-chloramines.
        J Clin Lab Anal. 1992; 6: 47-53
        • Loeckie L.Z.
        • Meerman J.H.N.
        • Commandeur J.N.M.
        • Vermeulen N.P.E.
        Biomarkers of free radical damage: applications in experimental animals and in humans.
        Free Radic Biol Med. 1999; 26: 202-226
        • Matteucci E.
        • Giampietro O.
        Oxidative stress in families of type 1 diabetic patients.
        Diab Care. 2000; 23: 1182-1186
        • Metzger B.E.
        • Coustan D.R.
        Proceedings of the fourth international workshop-conference on gestational diabetes mellitus.
        Diab Care. 1998; 21: B1-B167
        • Karacay O.
        • Sepici-Dincel A.
        • Karcaaltincaba D.
        • Sahin D.
        • Yalvaç S.
        • Akyol M.
        • et al.
        A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation.
        Diab Res Clin Pract. 2010 Sep; 89: 231-238
        • Mackness M.I.
        • Harty D.
        • Bhatnagar D.
        • Winocour P.H.
        • Arrol S.
        • Ishola M.
        • et al.
        Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.
        Atherosclerosis. 1991; 86: 193-199
        • Abbott C.A.
        • Mackness M.I.
        • Kumar S.
        • Boulton A.J.
        • Durrington P.N.
        Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.
        Arterioscler Thromb Vasc Biol. 1995; 15: 1812-1818
        • Cederberg J.
        • Basu S.
        • Eriksson U.J.
        Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy.
        Diabetologia. 2001; 44: 766-774
        • Carpenter M.W.
        • Coustan D.R.
        Criteria for screening tests for gestational diabetes.
        Am J Obstet Gynecol. 1982; 144: 768-773
        • Bridges A.B.
        • Fisher T.C.
        • Scott N.
        • McLaren M.
        • Belch J.J.
        Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers.
        Free Radic Res. 1992; 16: 89-97
        • Hasselwander O.
        • Savage D.A.
        • McMaster D.
        • Loughrey C.M.
        • McNamee P.T.
        • Middleton D.
        • et al.
        Paraoxonase polymorphism is not associated with cardiovascular risk in renal transplants recipients.
        Kidney Int. 1999; 56: 289-298
        • Saha N.
        • Roy A.C.
        • Teo S.H.
        • Tay J.S.
        • Ratnam S.S.
        Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins.
        Clin Genet. 1991; 40: 277-282
        • Cakatay U.
        • Kayali R.
        • Uzun H.
        Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population.
        Clin Exp Med. 2008; 8: 51-57
        • Gay C.A.
        • Gebicki J.M.
        Measurement of protein and lipid hydroperoxides in biological systems by the ferric-xylenol orange method.
        Anal Biochem. 2003; 315: 29-35
        • Witko-Sarsat V.
        • Friedlander M.
        • Capeillère-Blandin C.
        • Nguyen-Khoa T.
        • Nguyen A.T.
        • Zingraff J.
        • et al.
        Advanced oxidation protein products as a novel marker of oxidative stress in uremia.
        Kidney Int. 1996; 49: 1304-1313
        • Telci A.
        • Cakatay U.
        • Kayali R.
        • Erdoğan C.
        • Orhan Y.
        • Sivas A.
        • et al.
        Oxidative protein damage in plasma of type 2 diabetic patients.
        Horm Metab Res. 2000; 32: 40-43
        • Telci A.
        • Cakatay U.
        • Salman S.
        • Satman I.
        • Sivas A.
        Oxidative protein damage in early stage Type 1 diabetic patients.
        Diab Res Clin Pract. 2000; 50: 213-223
        • Salman-Tabcheh S.
        • Guérin M.C.
        • Torreilles J.
        Nitration of tyrosyl-residues from extra- and intracellular proteins in human whole blood.
        Free Radic Biol Med. 1995; 19: 695-698
        • Cakatay U.
        Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control.
        Diabetes Metab. 2005; 31: 551-557
        • Coughlan M.T.
        • Vervaart P.P.
        • Permezel M.
        • Georgiou H.M.
        • Rice G.E.
        Altered placental oxidative stress status in gestational diabetes mellitus.
        Placenta. 2004; 25: 78-84
        • Horváth E.M.
        • Magenheim R.
        • Kugler E.
        • Vácz G.
        • Szigethy A.
        • Lévárdi F.
        • et al.
        Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies.
        Diabetologia. 2009; 52 ([Epub July 14, 2009]): 1935-1943